
Sateesh Andra
Managing Partner
Enterprise technology, semiconductors and industrial technology
LinkedIn profile ↗India / Direct investor

Indian-built technology, from early conviction to global scale.
Operator-led early-stage fund backing product and IP-led companies in enterprise technology, industrial technology, healthcare and life sciences.
Connect Now01 / The fund
Globally relevant product companies with their own technology and intellectual property. Endiya invests across enterprise AI, cybersecurity, semiconductors, industrial robotics, intelligent mobility, diagnostics and life sciences, alongside selected fintech businesses.
The official approach is seed and pre-Series A, usually as the first institutional investor. The firm describes itself as an operator and co-founder VC, working with founders on product, hiring, customers and later fundraising.
Cheque figures have different dates and meanings. In November 2025, Sateesh Andra described INR 20-25 crore initial investments and INR 40-50 crore across rounds. In September 2026, he described $7M-$8M per company, and $10M-$25M for performing companies. The later figures are not presented as first-cheque amounts. Fund III was reported closed at INR 800 crore in March 2025 and described as about $100M in September 2026.
Official investment approach ↗02 / Portfolio
37 distinct holdings on the current official portfolio page. Eight are marked exited, including secondary sales; Kissht has an IPO badge while still labelled active. Two newer listings have no status label. DTT groups the full list by technology, without treating every holding as deep tech.

Biotech company dedicated to advancing cancer treatment through affordable NK cell therapies.
Holding source ↗
Fabless semiconductor company building ultra-high resolution, low power imaging radar chips.
Current company destination not verified.
Holding source ↗
AI-native semiconductor verification company building the verification trust layer for AI-driven chip design
Holding source ↗
Industrial Physical Intelligence platform for AI-native manufacturing automation
Holding source ↗
Biophysical Intelligence company building machines that sense, model, and adapt to the human body in real time
Holding source ↗
AI-enabled supply chain visibility, serialization, track & trace and compliance platform for regulated industries
Holding source ↗
Cloud-native, mobile-first HRMS solution for the entire employee life cycle - Hire to Retire.
Holding source ↗
Employee health benefits platform providing preventive, predictive and personalized healthcare services.
Holding source ↗
Enabling India’s EV and renewable energy revolution through reliable, scalable, and tech-driven infrastructure execution.
Holding source ↗
Alternative asset platform for retail investors creating wealth through leases, inventory / trade financing and bonds.
Holding source ↗
Technology first oncology platform for comprehensive cancer care.
Holding source ↗
Personal loans and loans against property (LAP) to retail customers and micro businesses, through a fully digital and fast disbursement process.
Holding source ↗
Next generation monetization platform for seamless implementation of complex billing models.
Holding source ↗
Agentic AI Product Intelligence platform transforming customer feedback into autonomous product decision-making and execution intelligence
Holding source ↗
Equity management platform for private markets - Captable / ESOP management and private market liquidity.
Holding source ↗
Risk-focused GRC automation platform that helps simplify and streamline compliance/information security for cloud-native companies.
Holding source ↗
Independent business assurance layer for enterprise systems and AI agents.
Holding source ↗
Cloud first real-time bot prevention platform for web and mobile applications.
Current company destination not verified.
Holding source ↗
A digital health platform preventing, managing & reversing type 2 diabetes & pre-diabetes with data-driven, consumer-centric care
Holding source ↗
Identity governance and SaaS management platform for enterprises.
Holding source ↗03 / Team & connect

Managing Partner
Enterprise technology, semiconductors and industrial technology
LinkedIn profile ↗
Managing Director
Digital health, medical devices and life sciences
LinkedIn profile ↗





All nine are listed under investments on the official site. Abhiram also handles fund strategy and operations, but is included because his official biography names direct investments. The firm prefers quality referrals from founders, portfolio companies and its wider network.
Official founder contact ↗04 / Fund network
Institutional LPs with the source scope kept intact. Unnamed family offices are not turned into speculative individual LP profiles.
Fund III LP
Signed commitment announced by AIIB in October 2024; its project document approved up to $10M.
Investor source ↗Reported Fund III LP
Named as a Fund III institutional backer in March 2025 reporting.
Investor source ↗Reported platform LP
Named in the institutional roster across Endiya funds. A specific fund allocation was not established.
Investor source ↗Reported platform LP
Named in the institutional roster across Endiya funds. A specific fund allocation was not established.
Investor source ↗Reported platform LP
Named as Nippon in the reported institutional roster. No more specific legal entity or fund allocation is asserted.
Investor source ↗